Review
Published on 11 Jan 2017
Different Pathways Leading to Integrase Inhibitors Resistance
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2016.02165
- 12,417 views
- 23 citations
14 articles related to "Integrase Inhibitors"
Articles
Original Research
Published on 16 Jul 2025
Use of the Lorenz curve and the Gini index for the evaluation of HIV viral load distribution in an Italian community
in Infectious Diseases: Epidemiology and Prevention
Frontiers in Public Health
doi 10.3389/fpubh.2025.1580633
- 1,236 views
Original Research
Published on 21 Oct 2022
A machine learning-based virtual screening for natural compounds capable of inhibiting the HIV-1 integrase
in Anti-Infective Agents
Frontiers in Drug Discovery
doi 10.3389/fddsv.2022.954911
- 6,782 views
- 12 citations
Original Research
Published on 29 Jan 2024
Human iPSC-derived neurons reveal NMDAR-independent dysfunction following HIV-associated insults
in Brain Disease Mechanisms
Frontiers in Molecular Neuroscience
doi 10.3389/fnmol.2023.1353562
- 3,980 views
- 1 citation
Original Research
Published on 18 Oct 2023
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1257725
- 4,465 views
- 6 citations
Original Research
Published on 14 Sep 2022
Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China
in Evolutionary and Genomic Microbiology
Frontiers in Genetics
doi 10.3389/fgene.2022.975397
- 5,193 views
- 10 citations
Original Research
Published on 20 Mar 2020
Drug Resistance Mutations Against Protease, Reverse Transcriptase and Integrase Inhibitors in People Living With HIV-1 Receiving Boosted Protease Inhibitors in South Africa
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2020.00438
- 10,684 views
- 26 citations
Original Research
Published on 03 Sep 2019
Raltegravir-Induced Adaptations of the HIV-1 Integrase: Analysis of Structure, Variability, and Mutation Co-occurrence
in Virology
Frontiers in Microbiology
doi 10.3389/fmicb.2019.01981
- 7,942 views
- 7 citations
Original Research
Published on 13 Aug 2019
Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
in Medicinal and Pharmaceutical Chemistry
Frontiers in Chemistry
doi 10.3389/fchem.2019.00574
- 24,393 views
- 47 citations
Original Research
Published on 28 Feb 2024
Outcomes of severely ill patients with AIDS treated with efavirenz or dolutegravir: a multicenter, observational study
in Infectious Diseases: Pathogenesis and Therapy
Frontiers in Medicine
doi 10.3389/fmed.2024.1302710
- 2,346 views
- 3 citations
Clinical Trial
Published on 11 Jul 2024
Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2024.1423734
- 4,301 views
- 7 citations
Review
Published on 24 Nov 2021
Transmitted Drug Resistance in Antiretroviral Therapy-Naive Persons With Acute/Early/Primary HIV Infection: A Systematic Review and Meta-Analysis
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2021.718763
- 9,494 views
- 36 citations
Original Research
Published on 05 Nov 2025
Prevalence of primary HIV-1 drug resistance among antiretroviral-naïve individuals in Togo in 2023: a national study
in Infectious Diseases: Epidemiology and Prevention
Frontiers in Public Health
doi 10.3389/fpubh.2025.1605763
- 1,842 views
- 1 citation
Original Research
Published on 19 Mar 2018
Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study
in HIV and AIDS
Frontiers in Public Health
doi 10.3389/fpubh.2018.00063
- 6,428 views
- 8 citations